X0306 4 2019-06-27 0 0001434316 FATE THERAPEUTICS INC FATE 0001586892 Shoemaker Daniel D C/O FATE THERAPEUTICS, INC.; 3535 GENERAL ATOMICS COURT #200 SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2019-06-27 4 M 0 12500 2.90 A 148091 D Common Stock 2019-06-27 4 S 0 12500 20.2088 D 135591 D Stock Option (right to buy) 2.90 2019-06-27 4 M 0 12500 D 2026-01-07 Common Stock 12500 123800 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018. Represents the weighted average sale price of the shares sold ranging from $19.65 to $20.47 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 8, 2016 such that this option is fully exercisable on January 8, 2020. Not applicable. /s/ Cindy R. Tahl, as Attorney-in-Fact 2019-06-28